Hemp Legalization & Regulatory News for Hemp Businesses

Ongoing hemp-transport questions trigger Minnesota warning

A Minnesota hemp industry group is warning manufacturers not to order hemp biomass from other states in the wake of a South Dakota drug arrest of a deliveryman bringing plants from Colorado to Minnesota for extraction. The Minnesota warning comes as a federal appeals court prepares to hear arguments next week over hemp transportation. “The ability […]

Read More

EPA seeking industry input on pesticide applications for hemp production

Federal pesticide regulators are reviewing products for use on hemp, a major step toward making the newly legal crop a national commodity. The U.S. Environmental Protection Agency (EPA) on Wednesday asked for public comment on 10 pesticide applications it has received. The EPA “is taking the next step toward registering crop-protection tools for hemp in time for […]

Read More

USDA: National THC test for hemp ‘as challenging as you think it is’

Federal agriculture authorities are struggling to craft a nationwide THC testing standard so that state and local regulators can tell hemp from marijuana, complicating the release of standardized production rules, according to an official with the U.S. Department of Agriculture (USDA). William Richmond, head of the Specialty Crops Program in the USDA’s Agricultural Marketing Service, […]

Read More

FDA exec: Don’t expect an exception for CBD

CBD treatments are promising, but far more research needs to be done before federal authorities can allow them in foods and dietary supplements, according to a leader of the U.S. Food and Drug Administration’s new cannabinoid work group. Talking to the National Industrial Hemp Council, Lowell Schiller warned CBD producers in attendance that the FDA […]

Read More

Brownstein Hyatt cites growth of industrial hemp in formation of industry group

With industrial hemp and recreational/medical marijuna becoming what it calls more “mainstream,” law firm and lobbying giant Brownstein Hyatt Farber Schreck said it has created a new industry group to accommodate the maturing markets. The group will be co-chaired by Melissa Kuipers Blake, a shareholder in the Denver-based firm’s government relations department, and Amy Steinfeld, […]

Read More

No Wyoming hemp cultivation in 2019, but THC testing close, governor says

Though Wyoming farmers can’t yet grow hemp, the state said its lab to test the crop for THC is almost ready. Wyoming Gov. Mark Gordon and the state Department of Agriculture sent an update this week to would-be hemp farmers reminding them that production remains illegal until federal agriculture authorities set national rules and then approve […]

Read More

Alaska governor cuts funding for hemp program, cites no existing industry

After developing proposed rules in June for its 2019 hemp production regulations, Alaska officials have determined a state industrial hemp program may not be worth funding. Republican Gov. Mike Dunleavy cut $375,000 from the state budget for Alaska’s industrial hemp program, saying there is “no existing industry to support a state-funded program.” Under a bill […]

Read More

Hemp for animal feed: Economic potential waits out legal maneuvering

Given hemp’s new legal status, many farmers and livestock producers want to explore cannabis for animal feed and the research that suggests its nutritional and developmental benefits. But they’re facing market and legal uncertainties that are familiar to those making hemp products for people. A 2017 Colorado study cited “a lack of domestic economic data” […]

Read More

Ohio governor enacts hemp law opening CBD sales beyond dispensaries

Ohio Gov. Mike DeWine signed into law a measure authorizing CBD sales and the commercial production of industrial hemp in the state. The law takes effect immediately and allows CBD to be sold outside dispensaries. CBD had been legal in Ohio but only in medical marijuana dispensaries. Highlights of the Ohio hemp law include: CBD food, […]

Read More

Curaleaf scrubs website for medical claims following FDA warning

After federal regulators warned cannabis giant Curaleaf last week against making unsubstantiated medical claims for its CBD products, the company has taken action. The Massachusetts cannabis company removed its blog and deleted social media posts and articles on its website saying its products can be used to treat medical conditions such as cancer, Alzheimer’s disease, chronic […]

Read More

European Medicines Agency panel OKs GW Pharma’s cannabis drug

The Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex, said the drug’s maker, GW Pharmaceuticals. The CHMP is tasked with preparing the European Medicines Agency’s opinions on queries about the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now […]

Read More